Interview with Padraig Somers, General Manager, Helsinn Birex
Mr. Somers, can you please introduce us to the Helsinn Group and its unique in-licensing model? Helsinn is a Swiss-based, private company owned by the Braglia family. The Braglias have…
Address: Takeda Ireland Limited (Bray), Bray Business park, Kilruddery, Co. Wicklow, ,Ireland
Tel: +353 (0)1 2050600
Takeda Ireland Limited (TIL) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, a global research-based pharmaceutical company, the No 1 pharmaceutical company in Japan, and one of the world’s top 100 companies.
Established in Ireland since 1997, Takeda employs over 400 people in the following areas: manufacturing of drug products (DP), active pharmaceutical ingredients (API), process development, packaging, supply chain, sales and marketing.
Takeda Ireland Ltd – Bray (DP)
TIL Bray, a wholly-owned subsidiary of Takeda Pharmaceutical Company has played a key role in Takeda’s worldwide operations since being established in 1997. To date employing over 400 people and serving as the main pharmaceutical production base for blockbuster products to the European and U.S markets.
Takeda Ireland Ltd – Grange Castle (API)
In 2002 the first Takeda API (Active Pharmaceutical Ingredient) plant outside Japan was constructed in Clondalkin, Dublin 22, representing a key strategic addition to the group’s global production network. The plant will be the launch vehicle for new strategic products for global markets developing and producing API’s from clinical trial stages through to launch and full commercialisation.
Takeda Products Ireland Ltd
Based in Citywest, Takeda Products Ireland Limited was established to market Takeda’s products throughout the Republic of Ireland. Takeda Products Ireland Limited is dedicated to improving Irish patients’ lives by bringing to the market, new and better medicines, developed by Takeda and key partners, to help address the nation’s most pressing healthcare needs. This includes debilitating conditions in key areas such as Cancer, Pulmonary disease, Cardiovascular disease, Type II Diabetes and Pain Management. Our current product portfolio includes Prostap, Mepact, Actos, Competact, Blopress, Blopress Plus, Edarbi, Midon, Instanyl, Matrfien, Xeforapid, Daxas, Protium, Somac Control, Preotact, Alvesco and Tachosil.
Prostap, Mepact, Actos, Competact, Blopress, Blopress Plus, Edarbi, Midon, Instanyl, Matrfien, Xeforapid, Daxas, Protium, Somac Control, Preotact, Alvesco and Tachosil.
Mr. Somers, can you please introduce us to the Helsinn Group and its unique in-licensing model? Helsinn is a Swiss-based, private company owned by the Braglia family. The Braglias have…
Ms. Dickens, in our interview with your Sanofi colleague Jan Hendrix in Belgium last month, he commented that it is amazing how diversified this company has become in just the…
Can you give us a sense of the history of this company and its Irish roots? The company started life in the UK and has always been a GI franchise…
Mr. Hanlon, can you please begin by introducing Clonmel Healthcare to our readers? Clonmel Healthcare was founded by an Irish family in the 1970’s. During this time, its primary goal…
Mr. Hynds, you were personally instrumental in leading the establishment of Actavis in Ireland in 2008. You commented at the time, ‘Historically, Actavis grew by acquisition in other markets, but…
Mr. Martin, you were appointed as Genzyme’s GM for UK and Ireland last month after having spent a decade at the organization. Robin Kenselaar, Head of Genzyme EMEA, noted that…
Mr. Looney, what has it been like to run this business for 26 years? Looking back, what can you say that you have built? It has certainly been an exciting…
Dr. Coveney, what motivated you to start this company? I had been working for the multinationals for a number of years—Schering Plough, and a number of other organizations. In 1999,…
In 2008, MSD began building a human vaccine facility in Carlow—a 220MN EUR investment that the company expanded upon last year with an additional 7Mn EUR. What is the importance…
This interview also features the comments of Brendan Fitzpatrick, Vice President Finished Goods Manufacturing. Ms. Murphy, your transition to your current position was precipitated by a major refocusing that LEO…
Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.” More recently, Time Magazine put Taoiseach Enda Kenny…
Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.” More recently, Time Magazine put Taoiseach Enda Kenny…
See our Cookie Privacy Policy Here
